Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
The Journal of Clinical Investigation|June 3, 2006
Defective regulatory and effector T cell functions in patients with FOXP3 mutationsRosa Bacchetta, Laura Passerini, Eleonora Gambineri, et al.Clinical Immunology (Orlando, Fla.)|February 5, 2024
IL-10-producing regulatory cells impact on celiac disease evolutionLaura Passerini, Giada Amodio, Virginia Bassi, et al.Blood|September 10, 2009
Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutationsSara Di Nunzio, Massimiliano Cecconi, Laura Passerini, et al.Frontiers in Immunology|March 2, 2018
Corrigendum: Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific ResponsesAnja Ten Brinke, Natalia Marek-Trzonkowska, Maria J Mansilla, et al.Frontiers in Immunology|January 10, 2018
Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific ResponsesAnja Ten Brinke, Natalia Marek-Trzonkowska, Maria J Mansilla, et al.Molecular Therapy. Methods & Clinical Development|August 18, 2025
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type IGiada De Ponti, Ludovica Santi, Giorgia Dina, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|August 21, 2024
Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potentialLudovica Santi, Stefano Beretta, Margherita Berti, et al.Journal of Autoimmunity|May 24, 2023
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseasesLaura Passeri, Grazia Andolfi, Virginia Bassi, et al.Molecular Therapy. Methods & Clinical Development|September 16, 2024
A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVBStefania Crippa, Gaia Alberti, Laura Passerini, et al.The Journal of Allergy and Clinical Immunology|December 25, 2019
Treatment with rapamycin can restore regulatory T-cell function in IPEX patientsLaura Passerini, Federica Barzaghi, Rosalia Curto, et al.Pageof 5